Deciphera Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Deciphera Pharmaceuticals
Q1 2024
10 May, 2024
Corporate Presentation
8 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Deciphera Pharmaceuticals Inc
Access all reports
Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on the development of kinase inhibitors to treat cancer. The company conducts clinical research and commercializes small-molecule therapies for solid tumors and hematologic malignancies. It is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
DCPH
Country
🇺🇸 United States